daratumumab (darzalex) Report issue

Biologics mAb Orphan Drug FDA Approved FDA First in Class Fast Track FDA Accelerated Approval FDA Priority Review FDA
Back

Drug Pricing Summary

VA Big4

$388.8300 - $1558.3100

AUS PBS

$452.9225 - $1811.6900

VA FSS

$534.2700 - $2137.1200

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
daratumumab 100 mg / 5 mL (5 mL INJECTION) $388.8300 VA Big4
  • DARZALEX (1)
  • J & J Health Care Systems on behalf of Janssen Biotech Inc.
    daratumumab 100 mg / 5 mL (5 mL INJECTION) $452.9225 AUS PBS generic
  • Darzalex (1)
  • Janssen-Cilag Pty Ltd
    daratumumab 100 mg / 5 mL (5 mL INJECTION) $534.2700 VA FSS
  • DARZALEX (1)
  • J & J Health Care Systems on behalf of Janssen Biotech Inc.
    daratumumab 100 mg / 5 mL (5 mL INJECTION) $1558.3100 VA Big4
  • DARZALEX (1)
  • J & J Health Care Systems on behalf of Janssen Biotech Inc.
    daratumumab 100 mg / 5 mL (5 mL INJECTION) $2137.1200 VA FSS
  • DARZALEX (1)
  • J & J Health Care Systems on behalf of Janssen Biotech Inc.
    daratumumab 400 mg / 20 mL (INJECTION) $1811.6900 AUS PBS generic
  • Darzalex (1)
  • Janssen-Cilag Pty Ltd

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue